|
1998. 04.
23 |
Incorporated (Capital for
establishment : 240 million won, CEO of Shin
Jeong Cheol)
|
| 1998. 07.
10 |
Inaugurated CEO
of Kim Wan Ju
|
| 1998. 07.
15 |
Moved its main
office in Yongin
|
| 1998. 08.
01 |
Established the
central research institute
|
| 1998. 09.
10 |
Registered the
affiliated research institute (Korea Industrial
Technology Promotion Association)
|
| 1998. 11.
24 |
Applied a patent
of manufacturing method
Chlarithromycin
|
| 1998. 12.
31 |
Issued a credit
cover from Technology Credit Guarantee
Foundation (Technology Credit Guarantee
Foundation)
|
| 1999. 01.
04 |
Registered as a
venture firm (SMBA : No.:
1999162238-0445)
|
| 1999. 02.
08 |
Applied a patent
of Imipenem manufacturing
method |
| 1999. 03.
24 |
Signed a
contract of the innovative technology development
business with SMBA
|
| 1999. 04.
01 |
Signed an
agreement of Industrial based technology
development business with MOCIE (Ministry of Commerce,
Industry and Energy) (about Imipenem
assignment)
|
| 1999. 04.
08 |
Applied a patent
of the Terbinafine manufacturing
method |
| 1999. 04.
22 |
Attracted capitals from
three investors on venture
companies |
| 1999. 05.
26 |
Designate 4
directors (Lee Yeong Il, Yu Hyo Sang, Yun Jeong In
and Youn Byeong Hun)
|
| 1999. 06.
18 |
Signed a
contract of industrial based technology development
business with MOCIE (Chiro technology
assignment)
|
| 1999. 07.
01 |
Made a cooperative
contract of venture type small and medium
company technology development business with the
Ministry of Health and Welfare (Terbinafine
assignment)
|
| 1999. 09.
30 |
Applied a patent
of a Insulin polymerization method
|
| 1999. 10.
29 |
Applied a
Japanese patent of Cefamycin intermediate (Joint
application with Japan Otsuka
Chemicals) |
| 1999. 11.
06 |
Signed a taking
over contract of Namyangju factory facilities of
Bayer Korea
|
| 1999. 11.
16 |
Applied a patent
of Macrolide antibiotics manufacturing
method |
| 1999. 12.
07 |
Made a strategic
alliance contract and a research contract with
Hansolchemience
|
| 1999. 12.
24 |
Applied a patent
of Macrolide antibiotics manufacturing method
(PCT application from 45
countries) |
| 1999. 12.
30 |
Registered the
plant by renaming its company and its
representative and (Namyangju City
hall) |
| 2000. 01.
01 |
Registered C-TRI
Namyangju plant corporation
|
| 2000. 01.
13 |
Applied a patent
of the Coumarin intermediate manufacturing
method |
| 2000. 01.
15 |
Applied a patent
of BDTF manufacturing method
|
| 2000. 01.
18 |
Acquired a
pharmaceutical business approval through granting
contracts (Korea Food and Drug
Administration)
|
| 2000. 02.
11 |
Applied a patent
of the capsulation technology of the egg immune
antibody |
| 2000. 02.
26 |
Assigned a
strategic alliance contract of new drug development
(NO controllers ) with the medical resources
research center of Wonkwang University (NO
controllers)
|
| 2000. 03.
07 |
Applied a patent
of the immune protein manufacturing
method |
| 2000. 03.
07 |
Signed a
strategic alliance with Cell
Biotech |
| 2000. 04.
23 |
Signed a
contract of life resource development with
agricultural resources utilization research institute
of GyeongSang National University
|
| 2000. 06.
12 |
Relocated in
Gowun high technology science technology institute
under the central research center of Suwon
University |
| 2000. 06.
22 |
Changed the
location of the head office (Gowun high technology
science technology institute under Suwon
University)
|
| 2000. 06.
22 |
Signed a
cooperative development contract of a new Taxol
pharmaceutical preparation with
Hansolcamience
|
| 2000. 07.
24 |
Established Namyangju
research institute (registered affiliated
research institute)
|
| 2000. 11.
15 |
Accepted Administrator
Award of SMBA in the
30
th Precision
Technology Promotion Competition
|
| 2000. 11.
27 |
Registered as a
venture firm (SMBA : No.
2000163512-2481)
|
| 2000. 12.
07 |
Selected as an
excellent venture in the Bio Area from Daily
Economy (Won the Minister Award of Ministry of
Commerce, Industry and Energy,
MOCIE) |
| 2000. 12.
30 |
Selected an
outstanding company with technology competitive
power (SMBA, Technology No.
2001-138) |
| 2001. 04.
26 |
Signed a
strategic alliance of the post genome project with
Microzen |
| 2001. 07.
10 |
Established the
local research corporation in
Germany |
| 2001. 08.
24 |
Selected as a
top technology company (Technology Credit
Guarantee Foundation)
|
| 2001. 08.
25 |
Selected as a
trial company of technology development
(Industrial Bank of Korea)
|
| 2001. 10.
29 |
e-registered the
number of the venture firm (Technology Evaluation
Company, No. 2001162271-3694)
|
| 2001. 11.
01 |
Accepted the
Minister Award of MOCIE in the
5
th National
Venture Firm Competition
|
| 2001. 11.
26 |
Selected as an
Inno-Biz enterprise (SMBA No.
1069-0457) |
| 2001. 12.
21 |
Won the Governor
Award of Gyeoggi-do (2-326)
|
| 2002. 05.
30 |
Issued CB for
Postech Technology Investment
|
| 2002. 09.
25 |
Merged and
Acquired Chirogene (Capital: 3,937,010,500
won) |
| 2002. 11.
21 |
Applied a patent
of Cilastatin intermediate manufacturing method
(PCT application)
|
| 2002. 11.
21 |
Applied a patent
of Paroxetine manufacturing
method |
| 2003. 12.
11 |
Accepted Minister Award
of MOCIE in the
6
th Venture
Cooperation against the Industrial
Cooperation
|
| 2004. 02.
20 |
Issued CD of
Daehwa Pharm
|
| 2004. 03.
04 |
Inaugurated CEO
of Kim Wun Jang
|
| 2004. 04.
16 |
Retired Kim Wan
Ju’s 800,000 shares without consideration
(from 3,937,010,500 won to
3,537,010,500 won)
|
|
2004. 04.
16 |
Reduced its
capital at the same rate as 50% of stocks
(From
3,537,010,500 won to 1,768,505,000
won) |
